607 related articles for article (PubMed ID: 19211577)
1. Increased hydrophobic interactions of iclaprim with Staphylococcus aureus dihydrofolate reductase are responsible for the increase in affinity and antibacterial activity.
Oefner C; Bandera M; Haldimann A; Laue H; Schulz H; Mukhija S; Parisi S; Weiss L; Lociuro S; Dale GE
J Antimicrob Chemother; 2009 Apr; 63(4):687-98. PubMed ID: 19211577
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory properties and X-ray crystallographic study of the binding of AR-101, AR-102 and iclaprim in ternary complexes with NADPH and dihydrofolate reductase from Staphylococcus aureus.
Oefner C; Parisi S; Schulz H; Lociuro S; Dale GE
Acta Crystallogr D Biol Crystallogr; 2009 Aug; 65(Pt 8):751-7. PubMed ID: 19622858
[TBL] [Abstract][Full Text] [Related]
3. Structural comparison of chromosomal and exogenous dihydrofolate reductase from Staphylococcus aureus in complex with the potent inhibitor trimethoprim.
Heaslet H; Harris M; Fahnoe K; Sarver R; Putz H; Chang J; Subramanyam C; Barreiro G; Miller JR
Proteins; 2009 Aug; 76(3):706-17. PubMed ID: 19280600
[TBL] [Abstract][Full Text] [Related]
4. Iclaprim, a novel diaminopyrimidine for the treatment of resistant gram-positive infections.
Sincak CA; Schmidt JM
Ann Pharmacother; 2009 Jun; 43(6):1107-14. PubMed ID: 19435963
[TBL] [Abstract][Full Text] [Related]
5. Structure-based design of new DHFR-based antibacterial agents: 7-aryl-2,4-diaminoquinazolines.
Li X; Hilgers M; Cunningham M; Chen Z; Trzoss M; Zhang J; Kohnen L; Lam T; Creighton C; G C K; Nelson K; Kwan B; Stidham M; Brown-Driver V; Shaw KJ; Finn J
Bioorg Med Chem Lett; 2011 Sep; 21(18):5171-6. PubMed ID: 21831637
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of the novel diaminopyrimidine, iclaprim, in combination with folate inhibitors and other antimicrobials with different mechanisms of action.
Laue H; Weiss L; Bernardi A; Hawser S; Lociuro S; Islam K
J Antimicrob Chemother; 2007 Dec; 60(6):1391-4. PubMed ID: 17962215
[TBL] [Abstract][Full Text] [Related]
7. Iclaprim, a novel diaminopyrimidine with potent activity on trimethoprim sensitive and resistant bacteria.
Schneider P; Hawser S; Islam K
Bioorg Med Chem Lett; 2003 Dec; 13(23):4217-21. PubMed ID: 14623005
[TBL] [Abstract][Full Text] [Related]
8. Analysis of mutational resistance to trimethoprim in Staphylococcus aureus by genetic and structural modelling techniques.
Vickers AA; Potter NJ; Fishwick CW; Chopra I; O'Neill AJ
J Antimicrob Chemother; 2009 Jun; 63(6):1112-7. PubMed ID: 19383727
[TBL] [Abstract][Full Text] [Related]
9. Effect of human plasma on the antimicrobial activity of iclaprim in vitro.
Laue H; Valensise T; Seguin A; Hawser S; Lociuro S; Islam K
J Antimicrob Chemother; 2007 Dec; 60(6):1388-90. PubMed ID: 17951265
[TBL] [Abstract][Full Text] [Related]
10. Dihydrofolate reductase inhibitors as antibacterial agents.
Hawser S; Lociuro S; Islam K
Biochem Pharmacol; 2006 Mar; 71(7):941-8. PubMed ID: 16359642
[TBL] [Abstract][Full Text] [Related]
11. Novel dihydrofolate reductase inhibitors. Structure-based versus diversity-based library design and high-throughput synthesis and screening.
Wyss PC; Gerber P; Hartman PG; Hubschwerlen C; Locher H; Marty HP; Stahl M
J Med Chem; 2003 Jun; 46(12):2304-12. PubMed ID: 12773035
[TBL] [Abstract][Full Text] [Related]
12. Toward Broad Spectrum Dihydrofolate Reductase Inhibitors Targeting Trimethoprim Resistant Enzymes Identified in Clinical Isolates of Methicillin Resistant
Reeve SM; Si D; Krucinska J; Yan Y; Viswanathan K; Wang S; Holt GT; Frenkel MS; Ojewole AA; Estrada A; Agabiti SS; Alverson JB; Gibson ND; Priestley ND; Wiemer AJ; Donald BR; Wright DL
ACS Infect Dis; 2019 Nov; 5(11):1896-1906. PubMed ID: 31565920
[TBL] [Abstract][Full Text] [Related]
13. Cloning and characterization of a novel trimethoprim-resistant dihydrofolate reductase from a nosocomial isolate of Staphylococcus aureus CM.S2 (IMCJ1454).
Sekiguchi J; Tharavichitkul P; Miyoshi-Akiyama T; Chupia V; Fujino T; Araake M; Irie A; Morita K; Kuratsuji T; Kirikae T
Antimicrob Agents Chemother; 2005 Sep; 49(9):3948-51. PubMed ID: 16127079
[TBL] [Abstract][Full Text] [Related]
14. Surveillance of iclaprim activity: In vitro susceptibility of gram-positive pathogens collected from 2012 to 2014 from the United States, Asia Pacific, Latin American and Europe.
Huang DB; File TM; Dryden M; Corey GR; Torres A; Wilcox MH
Diagn Microbiol Infect Dis; 2018 Apr; 90(4):329-334. PubMed ID: 29306582
[TBL] [Abstract][Full Text] [Related]
15. Iclaprim activity against wild-type and corresponding thymidine kinase-deficient Staphylococcus aureus in a mouse protection model.
Huang DB; Park JH; Murphy TM
Eur J Clin Microbiol Infect Dis; 2019 Feb; 38(2):409-412. PubMed ID: 30483998
[TBL] [Abstract][Full Text] [Related]
16. Worldwide surveillance of Iclaprim activity: In Vitro susceptibility of gram-positive pathogens collected from patients with skin and skin structure infections from 2013 to 2017.
Huang DB; Charrier C; Hawser S
Diagn Microbiol Infect Dis; 2020 May; 97(1):115013. PubMed ID: 32081524
[TBL] [Abstract][Full Text] [Related]
17. Basis of selectivity of antibacterial diaminopyrimidines.
Baccanari DP; Kuyper LF
J Chemother; 1993 Dec; 5(6):393-9. PubMed ID: 8195830
[TBL] [Abstract][Full Text] [Related]
18. Multiple mutations modulate the function of dihydrofolate reductase in trimethoprim-resistant Streptococcus pneumoniae.
Maskell JP; Sefton AM; Hall LM
Antimicrob Agents Chemother; 2001 Apr; 45(4):1104-8. PubMed ID: 11257022
[TBL] [Abstract][Full Text] [Related]
19. Structure-based design of new dihydrofolate reductase antibacterial agents: 7-(benzimidazol-1-yl)-2,4-diaminoquinazolines.
Lam T; Hilgers MT; Cunningham ML; Kwan BP; Nelson KJ; Brown-Driver V; Ong V; Trzoss M; Hough G; Shaw KJ; Finn J
J Med Chem; 2014 Feb; 57(3):651-68. PubMed ID: 24428639
[TBL] [Abstract][Full Text] [Related]
20. Iclaprim, a diaminopyrimidine dihydrofolate reductase inhibitor for the potential treatment of antibiotic-resistant staphylococcal infections.
Peppard WJ; Schuenke CD
Curr Opin Investig Drugs; 2008 Feb; 9(2):210-25. PubMed ID: 18246524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
